Gene editing treatments that utilize CRISPR-Cas9 to target mutations in infants’ genes associated with spinal muscular atrophy (SMA) are showing promise, according to scientists involved in the project.
Understanding Spinal Muscular Atrophy
Spinal muscular atrophy affects approximately 1 in every 6,000 babies born worldwide. The disease is caused by a mutation in the SMN1 gene, which encodes a protein called survival motor neuron 1. This protein is crucial for the health of nerve cells and muscles.
The CRISPR-Cas9 Treatment Approach
The treatment being developed involves:
- Removing faulty copies of the SMN1 gene.
- Replacing them with healthy ones using CRISPR-Cas9 gene editing.
This method allows doctors to edit out disease-causing mutations without altering other parts of the genome.
Dr. David Liu, a scientist working on the project, stated, "This is an exciting development because it could potentially cure SMA. We’re making good progress, but there are still significant challenges to overcome before we can make this treatment widely available."
Challenges in Treatment Development
Several challenges must be addressed to make this treatment viable:
-
Safe Delivery:
- Delivering therapies safely into cells deep within tissues like muscles and brains is critical.
- Scientists need to develop methods for delivering multiple edits simultaneously while avoiding off-target effects.
-
Scaling Production:
- There is a need to scale up production to ensure enough doses can be produced quickly for large populations.
- Current manufacturing processes must be enhanced to produce millions or billions of doses.
-
Current Delivery Methods:
- Most treatments currently use viral vectors or liposomes to carry genetic material into cells.
- These methods have limitations, such as low efficiency and high toxicity, restricting their use to small-scale clinical trials.
Dr. Liu emphasized the need for new technologies that can deliver these therapies efficiently and safely. He has been studying various delivery methods, including:
- Viral vectors
- Liposomes
- Electroporation
- Microinjection
- Laser-induced pressure wave technology
- Ultrasound microbubble destruction
- Optogenetics
- Photoelectroporation
- Photoacoustic ablation
- Photothermal ablation
- Photodynamic therapy
- Pulsed electric fields
- Electropermeabilization
- Nanobubble-mediated delivery
- Bioluminescence-guided delivery
Long-Term Considerations
Researchers also need a better understanding of:
- How long-term expression works after gene editing.
- The implications of multiple edits occurring simultaneously, which could lead to unintended consequences, such as cancerous growths due to overexpression of certain proteins.
Optimism for the Future
Despite these challenges, scientists remain optimistic about the potential benefits of this technology, including:
- Improved quality of life
- Increased life expectancy
- Reduced healthcare costs
- Prevention of premature death
While it may take several years before this treatment becomes widely available, researchers believe it will be worth the wait, especially considering the potential benefits for patients seeking a safe and effective cure for devastating diseases like SMA.
As research continues, scientists hope to find ways to overcome the remaining hurdles, bringing hope to millions of families affected by spinal muscular atrophy around the world.
Since 2018, scientists have been working on developing treatments for SMA using CRISPR-Cas9 gene editing, having first demonstrated its effectiveness in mice models carrying human SMA mutations.
I’m Mark W. Lamplugh Jr., a visionary Chief Executive Officer, Board Member, and best-selling Author with over 25 years of experience driving significant revenue growth and optimizing ROI across the healthcare, wellness, and media industries. Throughout my career, I’ve consistently transformed underperforming operations into thriving ventures by building top-tier marketing organizations, implementing data-driven strategies, and leading transformational change. My empathetic, collaborative, and adaptable leadership style has allowed me to cultivate inclusive cultures of innovation, develop and retain top talent, and forge strong partnerships that fuel organizational success.
Adept in executive leadership, strategic business planning, and brand and marketing strategy, I have a proven track record of boosting annual revenues—achieving up to $1.3B in oncology over three years and generating $360M in mental health initiatives. My approach combines strategic vision with hands-on execution, as evidenced by my success in launching innovative facilities, expanding services for addiction and mental health care, and enhancing organizational brand visibility. As author of “The AI Marketing Playbook,” I contribute thought leadership on the integration of artificial intelligence in marketing, a role that showcases my commitment to staying at the forefront of industry innovation.
I also bring my insights and expertise to a broad audience as the host of cable tv & global streaming of “Street Level Marketing Show,” while my writing has been featured in major publications such as Entrepreneur, Business.com, The Startup, and Kivo Daily. Whether I’m implementing targeted digital marketing campaigns that engage over a million individuals monthly or overseeing multi-million dollar budgets to maximize return on investment, I approach every challenge with a combination of strategic planning, creative problem-solving, and unwavering dedication. Above all, I am passionate about expanding access to high-quality addiction and mental health care through innovative solutions that drive both patient outcomes and organizational growth.
Mark serves on the board of One World for Life, National Fire Heritage Center, and the Institute for Responder Wellness.
Mark (https://marklamplugh.com) is one of the top marketing executives in the United States and has revolutionized how companies reach potential clients thru influence, SEO, social, PR, and traditional marketing. His expertise in Marketing, Social Media, Digital Marketing, and Public Relations has generated millions of dollars in revenue for several national companies. Mark documents many of his techniques in his book “Beginners Guide to Social & Digital Media.” and “Marketing Playbook for Social Media,” which was named the top 100 social media marketing books of all time by Book Authority. He’s also a professional advocate for the behavioral and mental health of firefighters and other first responders. Marks articles have been published in Better Marketing, Startup Magazine, Social Media Today, Kivo Daily, Biz Catalyst 360, Fire Engineering, Firehouse Magazine, and several others.
One of his companies, niches, are marketing products and services to the public safety industry and their employees, specifically mental & behavioral health services. He can be reached for comment at ceo@influencemediasolutions.com
23,000 #1 Connections, 40,000,000 US B2B Contacts and 300,000,000 B2b/B2C email contacts as well as 1,000,000+ monthly social media reach. https://marklamplugh.com
